Natriuretic peptides: biomarkers for atrial fibrillation management
In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia. Therefore, identification of individuals at risk of AF development/recurrence or its associated complications has emerged as a hot topic in the field of cardiology. Recently, several biomarkers have been...
Gespeichert in:
| Veröffentlicht in: | Clinical research in cardiology 2020-08, Vol.109 (8), p.957-966 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 966 |
|---|---|
| container_issue | 8 |
| container_start_page | 957 |
| container_title | Clinical research in cardiology |
| container_volume | 109 |
| creator | Sepehri Shamloo, Alireza Bollmann, Andreas Dagres, Nikolaos Hindricks, Gerhard Arya, Arash |
| description | In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia. Therefore, identification of individuals at risk of AF development/recurrence or its associated complications has emerged as a hot topic in the field of cardiology. Recently, several biomarkers have been introduced to predict AF and its consequences; however, use of biomarkers in AF management has not been highly recommended by guidelines yet. While utilization of natriuretic peptides (NPs) including brain (B-type) NPs (BNPs) in heart failure management has been well established, their use in relation to AF has not been fully understood. Accordingly, this review article aimed at presenting an overview of the role of NPs in predicting AF development/recurrence as well as its complications and making suggestions for their use in management of patients with AF in clinical settings.
Graphic abstract |
| doi_str_mv | 10.1007/s00392-020-01608-x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2350093607</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2425995512</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-93723cb85109f863b4ebfc4e3fac31edc404aac59e6a240e7bf68260549899cb3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EoqXwAyxQJDZsAuNHnJgdqnhJCDawthx3Urk0SbETqfw9LilFYsHKlnzm-s4h5JTCJQXIrwIAVywFBilQCUW63iNjWkiaglRsf3cvxIgchbAAyChwcUhGnAEwycWYTJ9N513vsXM2WeGqczMM10np2tr4d_QhqVqfbBizTCpXerdcms61TVKbxsyxxqY7JgeVWQY82Z4T8nZ3-zp9SJ9e7h-nN0-p5XnWpYrnjNuyiCVUVUheCiwrK5BXxnKKMytAGGMzhdIwAZiXlSyYhEyoQilb8gm5GHJXvv3oMXS6dsFiLNRg2wfNeAaguIQ8oud_0EXb-ya200ywTKksoyxSbKCsb0PwWOmVd3HvT01BbxTrQbGOivW3Yr2OQ2fb6L6scbYb-XEaAT4AIT41c_S_f_8T-wVgHYbb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425995512</pqid></control><display><type>article</type><title>Natriuretic peptides: biomarkers for atrial fibrillation management</title><source>Springer Nature - Complete Springer Journals</source><creator>Sepehri Shamloo, Alireza ; Bollmann, Andreas ; Dagres, Nikolaos ; Hindricks, Gerhard ; Arya, Arash</creator><creatorcontrib>Sepehri Shamloo, Alireza ; Bollmann, Andreas ; Dagres, Nikolaos ; Hindricks, Gerhard ; Arya, Arash</creatorcontrib><description>In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia. Therefore, identification of individuals at risk of AF development/recurrence or its associated complications has emerged as a hot topic in the field of cardiology. Recently, several biomarkers have been introduced to predict AF and its consequences; however, use of biomarkers in AF management has not been highly recommended by guidelines yet. While utilization of natriuretic peptides (NPs) including brain (B-type) NPs (BNPs) in heart failure management has been well established, their use in relation to AF has not been fully understood. Accordingly, this review article aimed at presenting an overview of the role of NPs in predicting AF development/recurrence as well as its complications and making suggestions for their use in management of patients with AF in clinical settings.
Graphic abstract</description><identifier>ISSN: 1861-0684</identifier><identifier>EISSN: 1861-0692</identifier><identifier>DOI: 10.1007/s00392-020-01608-x</identifier><identifier>PMID: 32002634</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Arrhythmia ; Biomarkers ; Brain natriuretic peptide ; Cardiac arrhythmia ; Cardiology ; Complications ; Congestive heart failure ; Fibrillation ; Management ; Medicine ; Medicine & Public Health ; Peptides ; Review</subject><ispartof>Clinical research in cardiology, 2020-08, Vol.109 (8), p.957-966</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-93723cb85109f863b4ebfc4e3fac31edc404aac59e6a240e7bf68260549899cb3</citedby><cites>FETCH-LOGICAL-c375t-93723cb85109f863b4ebfc4e3fac31edc404aac59e6a240e7bf68260549899cb3</cites><orcidid>0000-0002-4894-8664</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00392-020-01608-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00392-020-01608-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32002634$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sepehri Shamloo, Alireza</creatorcontrib><creatorcontrib>Bollmann, Andreas</creatorcontrib><creatorcontrib>Dagres, Nikolaos</creatorcontrib><creatorcontrib>Hindricks, Gerhard</creatorcontrib><creatorcontrib>Arya, Arash</creatorcontrib><title>Natriuretic peptides: biomarkers for atrial fibrillation management</title><title>Clinical research in cardiology</title><addtitle>Clin Res Cardiol</addtitle><addtitle>Clin Res Cardiol</addtitle><description>In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia. Therefore, identification of individuals at risk of AF development/recurrence or its associated complications has emerged as a hot topic in the field of cardiology. Recently, several biomarkers have been introduced to predict AF and its consequences; however, use of biomarkers in AF management has not been highly recommended by guidelines yet. While utilization of natriuretic peptides (NPs) including brain (B-type) NPs (BNPs) in heart failure management has been well established, their use in relation to AF has not been fully understood. Accordingly, this review article aimed at presenting an overview of the role of NPs in predicting AF development/recurrence as well as its complications and making suggestions for their use in management of patients with AF in clinical settings.
Graphic abstract</description><subject>Arrhythmia</subject><subject>Biomarkers</subject><subject>Brain natriuretic peptide</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology</subject><subject>Complications</subject><subject>Congestive heart failure</subject><subject>Fibrillation</subject><subject>Management</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Peptides</subject><subject>Review</subject><issn>1861-0684</issn><issn>1861-0692</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kMtOwzAQRS0EoqXwAyxQJDZsAuNHnJgdqnhJCDawthx3Urk0SbETqfw9LilFYsHKlnzm-s4h5JTCJQXIrwIAVywFBilQCUW63iNjWkiaglRsf3cvxIgchbAAyChwcUhGnAEwycWYTJ9N513vsXM2WeGqczMM10np2tr4d_QhqVqfbBizTCpXerdcms61TVKbxsyxxqY7JgeVWQY82Z4T8nZ3-zp9SJ9e7h-nN0-p5XnWpYrnjNuyiCVUVUheCiwrK5BXxnKKMytAGGMzhdIwAZiXlSyYhEyoQilb8gm5GHJXvv3oMXS6dsFiLNRg2wfNeAaguIQ8oud_0EXb-ya200ywTKksoyxSbKCsb0PwWOmVd3HvT01BbxTrQbGOivW3Yr2OQ2fb6L6scbYb-XEaAT4AIT41c_S_f_8T-wVgHYbb</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Sepehri Shamloo, Alireza</creator><creator>Bollmann, Andreas</creator><creator>Dagres, Nikolaos</creator><creator>Hindricks, Gerhard</creator><creator>Arya, Arash</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4894-8664</orcidid></search><sort><creationdate>20200801</creationdate><title>Natriuretic peptides: biomarkers for atrial fibrillation management</title><author>Sepehri Shamloo, Alireza ; Bollmann, Andreas ; Dagres, Nikolaos ; Hindricks, Gerhard ; Arya, Arash</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-93723cb85109f863b4ebfc4e3fac31edc404aac59e6a240e7bf68260549899cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Arrhythmia</topic><topic>Biomarkers</topic><topic>Brain natriuretic peptide</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology</topic><topic>Complications</topic><topic>Congestive heart failure</topic><topic>Fibrillation</topic><topic>Management</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Peptides</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sepehri Shamloo, Alireza</creatorcontrib><creatorcontrib>Bollmann, Andreas</creatorcontrib><creatorcontrib>Dagres, Nikolaos</creatorcontrib><creatorcontrib>Hindricks, Gerhard</creatorcontrib><creatorcontrib>Arya, Arash</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical research in cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sepehri Shamloo, Alireza</au><au>Bollmann, Andreas</au><au>Dagres, Nikolaos</au><au>Hindricks, Gerhard</au><au>Arya, Arash</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Natriuretic peptides: biomarkers for atrial fibrillation management</atitle><jtitle>Clinical research in cardiology</jtitle><stitle>Clin Res Cardiol</stitle><addtitle>Clin Res Cardiol</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>109</volume><issue>8</issue><spage>957</spage><epage>966</epage><pages>957-966</pages><issn>1861-0684</issn><eissn>1861-0692</eissn><abstract>In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia. Therefore, identification of individuals at risk of AF development/recurrence or its associated complications has emerged as a hot topic in the field of cardiology. Recently, several biomarkers have been introduced to predict AF and its consequences; however, use of biomarkers in AF management has not been highly recommended by guidelines yet. While utilization of natriuretic peptides (NPs) including brain (B-type) NPs (BNPs) in heart failure management has been well established, their use in relation to AF has not been fully understood. Accordingly, this review article aimed at presenting an overview of the role of NPs in predicting AF development/recurrence as well as its complications and making suggestions for their use in management of patients with AF in clinical settings.
Graphic abstract</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>32002634</pmid><doi>10.1007/s00392-020-01608-x</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-4894-8664</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1861-0684 |
| ispartof | Clinical research in cardiology, 2020-08, Vol.109 (8), p.957-966 |
| issn | 1861-0684 1861-0692 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2350093607 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Arrhythmia Biomarkers Brain natriuretic peptide Cardiac arrhythmia Cardiology Complications Congestive heart failure Fibrillation Management Medicine Medicine & Public Health Peptides Review |
| title | Natriuretic peptides: biomarkers for atrial fibrillation management |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A30%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Natriuretic%20peptides:%20biomarkers%20for%20atrial%20fibrillation%20management&rft.jtitle=Clinical%20research%20in%20cardiology&rft.au=Sepehri%20Shamloo,%20Alireza&rft.date=2020-08-01&rft.volume=109&rft.issue=8&rft.spage=957&rft.epage=966&rft.pages=957-966&rft.issn=1861-0684&rft.eissn=1861-0692&rft_id=info:doi/10.1007/s00392-020-01608-x&rft_dat=%3Cproquest_cross%3E2425995512%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2425995512&rft_id=info:pmid/32002634&rfr_iscdi=true |